The Vascular Care Group Enrolls Nation’s First Patient in FORTAVENA Post-Market Study at Darien Vascular Center
The Vascular Care Group (TVCG) announced that its Darien, Connecticut vascular center has enrolled the first patient in the nation in the FORTAVENA Post-Market Study, formally titled “The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study.” The prospective, multicenter, single-arm study is designed to generate real-world clinical evidence on the safety and effectiveness of the GORE® […]